WAY-181187
CAS No. 554403-49-5
WAY-181187( WAY-181187 | WAY 181187 | WAY181187 )
Catalog No. M17540 CAS No. 554403-49-5
WAY-181187 has high-affinity binding at the human 5-HT6 receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 169 | In Stock |
|
| 5MG | 155 | In Stock |
|
| 10MG | 259 | In Stock |
|
| 25MG | 420 | In Stock |
|
| 50MG | 551 | In Stock |
|
| 100MG | 759 | In Stock |
|
| 200MG | 1004 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWAY-181187
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-181187 has high-affinity binding at the human 5-HT6 receptor.
-
DescriptionWAY-181187 is a potent and selective 5-HT6 receptor agonist. WAY-181187 possesses high affinity binding (2.2 and 4.8 nM, respectively) at the human 5-HT6 receptor and profile as full receptor agonists (WAY-181187: EC50=6.6 nM, Emax=93%). In the rat frontal cortex, acute administration of WAY-181187 (3-30 mg/kg, subcutaneous (s.c.)) significantly increased extracellular GABA concentrations without altering the levels of glutamate or norepinephrine.
-
In VitroWestern Blot Analysis Cell Line:HEK/HA-5-HT6 receptor cells Concentration:1 and 10 μM Incubation Time:Pretreatment 5 minutes Result:Increased activation of ERK1/2 both at 1 and 10 μM concentrations.
-
In VivoAnimal Model:Adult male Sprague-Dawley rats weighing 280–350 g Dosage:3, 10, or 30 mg/kg Administration:Acute dministered by s.c.Result:Significantly increased extracellular GABA concentrations without altering the levels of glutamate or norepinephrine.
-
SynonymsWAY-181187 | WAY 181187 | WAY181187
-
PathwayCell Cycle/DNA Damage
-
TargetTelomerase
-
Recptor5-HT6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number554403-49-5
-
Formula Weight380.87
-
Molecular FormulaC15H13ClN4O2S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (262.56 mM)
-
SMILESc1ccc2c(c1)c(cn2S(=O)(=O)c1c(nc2n1ccs2)Cl)CCN
-
Chemical Name2-(1-((6-Chloroimidazo(2,1-b)(1,3)thiazol-5-yl)sulfonyl)-1H-indol-3-yl)ethylamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
360A
360A is a stabilizing G-Quadruplex ligand and also inhibits telomerase activity for telomerase in TRAP-G4 assay(IC50 : 300 nM).
-
Antipsychotic agent ...
Antipsychotic agent 54 is a benzoylpiperidine compound that can be used in the study of central nervous system diseases such as psychosis and cognitive impairment.
-
Ceramides Mixture
Ceramides Mixture, an endogenous ceramide, consists of hydroxy and non-hydroxy fatty acid-containing ceramides. It is involved in the regulation of cell cycle arrest, growth inhibition, and modulation of telomerase activity.Endogenous Ceramides inhibits mRNA synthesis of telomerase reverse transcriptase and telomerase activity via inactivation of the c-Myc transcription factor in the A549 human lung adenocarcinoma cell line.
Cart
sales@molnova.com